MOSES: superiority or noninferiority?
Owen
Andrew
A
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000473:pathology; D002561:Cerebrovascular Disorders / Q000628:therapy; D002986:Clinical Trials as Topic; D003627:Data Interpretation, Statistical; D006801:Humans; D002546:Ischemic Attack, Transient / Q000628:therapy; D009568:Nitrendipine / Q000627:therapeutic use; D016016:Proportional Hazards Models; D012008:Recurrence; D012107:Research Design; D012307:Risk Factors; D020521:Stroke / Q000188:drug therapy* / Q000401:mortality* / Q000517:prevention & control; D016896:Treatment Outcome
D047228:Angiotensin II Type 1 Receptor Blockers; D009568:Nitrendipine